Advertisements


We are Sorry, This Page doesn't Exist


We could find out if Pfizer"s COVID-19 vaccine works in kids aged 2 to 11 by September

Albert Bourla, Pfizer CEO, said that trial data for the youngest age-group, 6 months to two years, would be ready to show to the FDA by November. Trial data.....»»

Category: dealsSource: nytMay 5th, 2021

Moderna expects to increase global 2022 capacity of COVID-19 vaccine to 3B doses

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 29th, 2021

Moderna, IBM to collaborate on COVID vaccine supply, distribution data sharing

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 4th, 2021

The EU has authorized Moderna"s COVID-19 vaccine, making it the second shot available in Europe

The European Medicines Agency said it had "thoroughly assessed" data related to Moderna's vaccine's quality, safety, and efficacy. A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we ha.....»»

Category: dealsSource: nytJan 6th, 2021

EU regulators recommended authorization of Moderna"s vaccine, clearing the way for Europe to get its second COVID-19 shot

The European Medicines Agency said it had "thoroughly assessed" data rela.....»»

Category: topSource: businessinsiderJan 6th, 2021

Moderna expects to deliver 100 million doses of its COVID-19 vaccine in the U.S. in Q1

Shares of Moderna Inc.....»»

Category: topSource: marketwatchJan 4th, 2021

Moderna expects COVID-19 vaccine to work against new variant, CNBC says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 23rd, 2020

After Pfizer, Moderna"s COVID-19 Vaccine Data Accessed In Cyberattack

Moderna Inc (NASDAQ: MRNA) said documents related to its COVID-19 vaccine were targeted by hackers in an attack on the European Medicines Agency (EMA), Reuters reported Monday. read more.....»»

Category: blogSource: benzingaDec 15th, 2020

After Pfizer, Moderna"s COVID-19 Vaccine Data Comprised In Cyberattack

Moderna Inc (NASDAQ: MRNA) said documents related to its COVID-19 vaccine were targeted by hackers in an attack on the European Medicines Agency (EMA), Reuters reported Monday. read more.....»»

Category: blogSource: benzingaDec 14th, 2020

Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress

Zacks.....»»

Category: topSource: redinewsApr 7th, 2020

Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development

Zacks.....»»

Category: topSource: redinewsApr 2nd, 2020

First data from trial of Moderna vaccine candidate for coronavirus could come by June: Evercore

The first set of immunogenicity data from the first trial of a potential vaccine to treat the coronavirus that causes COVID-19 could come as early as June, according to Evercore analyst Umer Ruffat. The National Institutes of Health.....»»

Category: topSource: marketwatchMar 16th, 2020

3 Sector ETFs to Bet On Despite Soft November Jobs Data

These sector ETFs should gain post November jobs data. U.S. employers added 155,000 jobs in November, after a downwardly revised 237,000 in October.....»»

Category: smallbizSource: nytDec 10th, 2018

Moderna TeenCOVE study of its COVID vaccine in adolescents meets endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

Moderna says its COVID-19 vaccine effective in kids as young as 12, will seek FDA approval

Moderna says its COVID-19 vaccine effective in kids as young as 12, will seek FDA approval.....»»

Category: topSource: chicagotribuneMay 25th, 2021

Moderna, Samsung Biologics announce manufacturing agreement of COVID vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 23rd, 2021

3 Wuhan lab workers were sick enough to be hospitalized in November 2019, triggering calls to reconsider theory that COVID-19 originated in a lab: WSJ

The Wuhan Institute of Virology hasn't released raw data or lab records on its work with coronaviruses in bats. The P4 laboratory at the Wuhan Institute of Virology in Wuhan in.....»»

Category: topSource: businessinsiderMay 23rd, 2021

Moderna announces MFDS authorization of COVID-19 vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2021

Moderna"s COVID-19 vaccine is authorized in South Korea

Shares of Moderna were down 2.0% in trading on Friday after the company said its COV.....»»

Category: topSource: marketwatchMay 21st, 2021

Takeda Pharmaceutical announces MHLW approval for Moderna COVID-19 vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2021